Study Shows GLP-1 Drugs Could Be Linked to Lower Addiction Risk
Do GLP-1 drugs biologically treat addiction or do results simply reflect healthier patient behavior patterns?
Above: Wegovy tablets and Ozempic injection pens. Image credit: Michael Siluk/UCG/Universal Images Group/Getty Images
The Spin
Narrative A
It's an extremely positive development that these drugs quiet the relentless craving that drives addiction by targeting shared reward pathways in the brain, offering hope where decades-old treatments have failed miserably. This isn't about willpower anymore; it's about treating addiction as the chronic biological disease it actually is.
Narrative B
This study suffers from adherer bias, as GLP-1 patients are simply more motivated and healthcare-engaged than comparison groups in ways no statistical adjustment can fix. Finding uniform protection across every tested substance screams confounding rather than a genuine drug effect.